Holen Sie sich die Stockscreener-App
11.59
0.74%
0.085
Handel nachbörslich:
11.59
Schlusskurs vom Vortag:
$11.51
Offen:
$11.75
24-Stunden-Volumen:
35,575
Relative Volume:
0.66
Marktkapitalisierung:
$9.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.93M
KGV:
-0.0435
EPS:
-266.137
Netto-Cashflow:
$-15.87M
1W Leistung:
+4.32%
1M Leistung:
+33.45%
6M Leistung:
-96.12%
1J Leistung:
-94.92%
1-Tages-Spanne:
$10.45
$11.75
1-Wochen-Bereich:
$10.16
$11.75
52-Wochen-Spanne:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Firmenname
Transcode Therapeutics Inc
Sektor
Branche
Telefon
857-301-6857
Adresse
6 LIBERTY SQUARE, BOSTON
Vergleichen Sie RNAZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
11.59 | 9.16M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten
Building trade automation scripts for TransCode Therapeutics Inc.Growth Watchlist for Long Term Positioning - Newser
Understanding TransCode Therapeutics Inc.’s price movementWeekly High Conviction Trade Setup Analysis - Newser
Top Risks to Consider Before Buying TransCode Therapeutics Inc. StockMomentum Detection with Entry Optimization - Newser
Can momentum traders help lift TransCode Therapeutics Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser
Using Ichimoku Cloud for TransCode Therapeutics Inc. technicalsAI Trading Forecast Based on Big Data - Newser
What makes TransCode Therapeutics Inc. stock price move sharplyReal-Time Equity Price Action Analysis - Newser
Using data models to predict TransCode Therapeutics Inc. stock movementFree AI Driven Stock Trend Forecast - Newser
When is the best time to exit TransCode Therapeutics Inc.Chart Driven Opportunity Scanner with Alerts - Newser
Is TransCode Therapeutics Inc. the Top Chart Pick This WeekTrade Scanner With Buy Zone Alerts Flagged - metal.it
Why ATCO.PRH stock attracts strong analyst attentionMarket Sentiment Tracker with Smart Alerts - Newser
Is TransCode Therapeutics Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
Does TransCode Therapeutics Inc. stock perform well during market downturnsExceptional profit margins - Jammu Links News
Is it the right time to buy TransCode Therapeutics Inc. stockTremendous return on equity - Jammu Links News
When is TransCode Therapeutics Inc. stock expected to show significant growthMaximize your portfolio’s earning potential - Jammu Links News
Why is TransCode Therapeutics Inc. stock attracting strong analyst attentionCapitalize on fast-growing investment opportunities - Jammu Links News
How does TransCode Therapeutics Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News
What institutional investors are buying TransCode Therapeutics Inc. stockBuild a winning investment portfolio - Jammu Links News
How volatile is TransCode Therapeutics Inc. stock compared to the marketUnprecedented growth rates - Jammu Links News
Relative strength of TransCode Therapeutics Inc. in sector analysisAI Screener Based Stock Summary Report - Newser
Will TransCode Therapeutics Inc. stock benefit from interest rate changesFree Low Risk Swing Trade Opportunity List - Newser
Using RSI to spot recovery in TransCode Therapeutics Inc.Triple Digit Gain Opportunity Watchlist - Newser
Analyzing recovery setups for TransCode Therapeutics Inc. investorsFree Trade Setups With AI Powered Filters - Newser
Signal strength of TransCode Therapeutics Inc. stock in tech scannersWatchlist Generator With Real-Time Entry - Newser
Candlestick signals on TransCode Therapeutics Inc. stock todayOptimized Watchlist With Daily Adjustments Launched - metal.it
Will breakout in TransCode Therapeutics Inc. lead to full recoveryFree Trend Following Strategy With Stop Loss - Newser
TransCode Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayEntry Optimization Tool with Screener Logic - Newser
Using flow based indicators on TransCode Therapeutics Inc.Technical Trend Forecast for Investors - Newser
Should you hold or exit TransCode Therapeutics Inc. nowMinimal Risk Growth Investment Opportunity Analysis - Newser
Real time alert setup for TransCode Therapeutics Inc. performanceVolume Spike Detection for Early Breakouts - Newser
Why TransCode Therapeutics Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
What’s next for TransCode Therapeutics Inc. stock priceStrong Buy With Technical Confidence Supported - metal.it
Is TransCode Therapeutics Inc. Stock a Good Fit for Conservative InvestorsFree Alpha Focused Technical Trade Signals - Newser
TransCode Therapeutics Inc. stock outlook for YEARFree High Growth Low Risk Stock Selection - Newser
How does TransCode Therapeutics Inc. generate profit in a changing economyMassive portfolio appreciation - Jammu Links News
What are analysts’ price targets for TransCode Therapeutics Inc. in the next 12 monthsRapid growth trajectories - jammulinksnews.com
DSGR stock prediction for this week Free Trade Scanner With Buy Zone Alerts - Newser
Candlestick signals on TransCode Therapeutics Inc. stock today Long-Term Investment Strategy Summary Guide - Newser
How many analysts rate TransCode Therapeutics Inc. as a “Buy”Discover undervalued stocks before they soar - jammulinksnews.com
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):